Q2 2023 Xeris Biopharma Holdings Inc Earnings Call Transcript
Good morning all. I would like to welcome you all to the Xeris Biopharma Second Quarter 2023 Financial Results Call. My name is Brika, and I will be your moderator for today's call. (Operator Instructions) I would now like to pass the conference over to your host, Allison Wey, Senior Vice President of Investor Relations and Corporate Communications, to begin. So Allison, please go ahead.
Thank you, Brika. Good morning, and welcome to Xeris BioPharma's Second Quarter Financial Results Conference Call and Webcast. A press release with the company's financial results was issued earlier this morning and can be found on our website. We are joined this morning by Paul Edick, Chairman and CEO; and Steve Pieper, our CFO. Paul will provide opening remarks, Steve will provide details on our financial results, then we will open the call for Q&A.
Before we begin, I would like to remind you that this call will contain forward-looking statements by which may include, but are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |